The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X (Electronic) Linking ISSN: 2218273X NLM ISO Abbreviation: Biomolecules Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI, 2011-

Matrix Metalloproteinases/*metabolism ; Peripheral Vascular Diseases/*metabolism ; Renal Insufficiency, Chronic/*metabolism; Animals ; Humans ; Kidney/metabolism ; Kidney/physiopathology ; Matrix Metalloproteinases/analysis ; Matrix Metalloproteinases/blood ; Peripheral Vascular Diseases/blood ; Peripheral Vascular Diseases/physiopathology ; Proteinuria/blood ; Proteinuria/metabolism ; Proteinuria/physiopathology ; Renal Insufficiency, Chronic/blood ; Renal Insufficiency, Chronic/physiopathology ; Vascular Calcification/blood ; Vascular Calcification/metabolism ; Vascular Calcification/physiopathology

: Chronic Kidney Disease (CKD) represents a risk factor for fatal and nonfatal cardiovascular (CV) events, including peripheral vascular disease (PVD). This occurs because CKD encompasses several factors that lead to poor prognoses, mainly due to a reduction of the estimated glomerular filtration rate (eGFR), the presence of proteinuria, and the uremic inflammatory milieu. The matrix metalloproteinases (MMPs) are a group of zinc-containing endopeptidases implicated in extracellular matrix (ECM) remodeling, a systemic process in tissue homeostasis. MMPs play an important role in cell differentiation, angiogenesis, inflammation, and vascular damage. Our aim was to review the published evidence regarding the association between MMPs, PVD, and CKD to find possible common pathophysiological mechanisms. MMPs favor ECM deposition through the glomeruli, and start the shedding of cellular junctions and epithelial-mesenchymal transition in the renal tubules. MMP-2 and -9 have also been associated with the presence of systemic vascular damage, since they exert a pro-inflammatory and proatherosclerotic actions. An imbalance of MMPs was found in the context of PVD, where MMPs are predictors of poor prognoses in patients who underwent lower extremity revascularization. MMP circulating levels are increased in both conditions, i.e., that of CKD and PVD. A possible pathogenic link between these conditions is represented by the enhanced production of transforming growth factor-β that worsens vascular calcifications and atherosclerosis and the development of proteinuria in patients with increased levels of MMPs. Proteinuria has been recognized as a marker of systemic vascular damage, and this may explain in part the increase in CV risk that is manifest in patients with CKD and PVD. In conclusion, MMPs can be considered a useful tool by which to stratify CV risk in patients with CKD and PVD. Further studies are needed to investigate the causal-relationships between MMPs, CKD, and PVD, and to optimize their prognostic and predictive (in response to treatments) roles.
Competing Interests: The authors declare no conflict of interest.

Am J Physiol Renal Physiol. 2007 Mar;292(3):F905-11. (PMID: 17190907)
Atherosclerosis. 2012 Feb;220(2):552-6. (PMID: 22169111)
J Am Heart Assoc. 2019 Apr 2;8(7):e011426. (PMID: 30890055)
Am J Kidney Dis. 2008 Sep;52(3):595-605. (PMID: 18725016)
Prog Mol Biol Transl Sci. 2017;148:31-65. (PMID: 28662825)
J Immunol. 2006 May 15;176(10):6022-33. (PMID: 16670311)
Cardiovasc Diabetol. 2017 Apr 26;16(1):55. (PMID: 28446168)
Am J Physiol Renal Physiol. 2012 Jun 1;302(11):F1351-61. (PMID: 22492945)
J Clin Lab Anal. 2004;18(3):206-10. (PMID: 15103687)
Arterioscler Thromb Vasc Biol. 1995 Aug;15(8):1145-51. (PMID: 7627708)
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5634-9. (PMID: 15064395)
Int J Nephrol. 2016;2016:9498013. (PMID: 27042350)
Kidney Int. 2006 Feb;69(3):538-45. (PMID: 16395261)
Atherosclerosis. 2003 Jul;169(1):139-46. (PMID: 12860260)
Circulation. 2003 Apr 1;107(12):1579-85. (PMID: 12668489)
Lancet. 2010 Jun 12;375(9731):2073-81. (PMID: 20483451)
J Atheroscler Thromb. 2012;19(2):149-58. (PMID: 22123215)
Kidney Int. 2010 Aug;78(4):363-73. (PMID: 20505657)
Thromb Res. 2008;121(4):543-8. (PMID: 17706748)
Int Urol Nephrol. 2015 Dec;47(12):1993-2001. (PMID: 26498629)
Nephron Clin Pract. 2010;115(4):c251-8. (PMID: 20424475)
Cardiovasc Res. 2006 Feb 15;69(3):562-73. (PMID: 16405877)
Physiol Rev. 2005 Jan;85(1):1-31. (PMID: 15618476)
Kidney Int. 2011 Jul;80(1):112-8. (PMID: 21451461)
N Engl J Med. 2004 Sep 23;351(13):1296-305. (PMID: 15385656)
Blood Purif. 2015;39(1-3):84-92. (PMID: 25662331)
Nephrol Dial Transplant. 2007 Apr;22(4):1115-22. (PMID: 17205957)
Curr Vasc Pharmacol. 2010 Jan;8(1):75-85. (PMID: 19485936)
J Vasc Surg. 1994 Nov;20(5):814-20. (PMID: 7526009)
J Vasc Res. 2008;45(4):357-62. (PMID: 18332634)
Pediatr Nephrol. 2011 Dec;26(12):2179-84. (PMID: 21720805)
J Invest Dermatol. 1998 Nov;111(5):822-7. (PMID: 9804345)
J Vasc Surg. 2008 Aug;48(2):447-56. (PMID: 18502086)
Clin Chim Acta. 2014 Mar 20;430:15-9. (PMID: 24389099)
Life Sci. 2018 Oct 1;210:125-131. (PMID: 30172705)
Kidney Blood Press Res. 2011;34(4):284-90. (PMID: 21691132)
PLoS One. 2017 Feb 17;12(2):e0172241. (PMID: 28212407)
Eur J Biochem. 2001 Apr;268(7):1918-28. (PMID: 11277914)
J Mol Biol. 2004 Aug 20;341(4):1063-76. (PMID: 15289103)
Cell. 2002 Nov 27;111(5):635-46. (PMID: 12464176)
J Am Soc Nephrol. 2003 Nov;14(11):2861-72. (PMID: 14569096)
Eur Heart J. 2004 Sep;25(17):1509-16. (PMID: 15342170)
Biochem Pharmacol. 2008 Jan 15;75(2):346-59. (PMID: 17678629)
PLoS One. 2011 Jan 19;6(1):e16185. (PMID: 21283828)
J Vasc Surg. 2001 Oct;34(4):606-10. (PMID: 11668312)
N Engl J Med. 2017 Aug 17;377(7):644-657. (PMID: 28605608)
Nephrol Dial Transplant. 2018 Nov 1;33(11):1942-1949. (PMID: 29509925)
Thromb Haemost. 2004 Sep;92(3):646-53. (PMID: 15351863)
Arterioscler Thromb Vasc Biol. 1996 Nov;16(11):1373-82. (PMID: 8911276)
BMC Cardiovasc Disord. 2005 Jun 22;5:14. (PMID: 15972099)
J Vasc Res. 2005 Sep-Oct;42(5):388-98. (PMID: 16088212)
Lancet Diabetes Endocrinol. 2015 Jul;3(7):514-25. (PMID: 26028594)
Kidney Blood Press Res. 2019;44(3):298-330. (PMID: 31185475)
Curr Cancer Drug Targets. 2005 May;5(3):203-20. (PMID: 15892620)
J Surg Res. 2003 May 1;111(1):8-15. (PMID: 12842442)
Am J Physiol Renal Physiol. 2007 Dec;293(6):F1927-34. (PMID: 17898039)
J Am Soc Nephrol. 1998 Mar;9(3):397-407. (PMID: 9513901)
Circulation. 1997 Oct 7;96(7):2228-32. (PMID: 9337194)
BMC Clin Pathol. 2009 Sep 16;9:7. (PMID: 19758433)
N Engl J Med. 2015 Nov 26;373(22):2117-28. (PMID: 26378978)
Nephrol Dial Transplant. 2020 Jan 1;35(1):138-147. (PMID: 30053127)
J Dermatol Sci. 2001 Apr;25(3):198-205. (PMID: 11240267)
Brief Bioinform. 2011 May;12(3):203-14. (PMID: 21324971)
J Intern Med. 2005 Jan;257(1):110-6. (PMID: 15606382)
Am J Pathol. 2008 Feb;172(2):299-308. (PMID: 18202193)
Drug Resist Updat. 2004 Jun;7(3):195-208. (PMID: 15296861)
G Ital Nefrol. 2019 Apr;36(2):. (PMID: 30983174)
Lancet Diabetes Endocrinol. 2017 Sep;5(9):718-728. (PMID: 28716631)
Biochem Cell Biol. 2008 Apr;86(2):124-36. (PMID: 18443626)
JAMA. 2016 Jan 12;315(2):164-74. (PMID: 26757465)
Circulation. 1994 Jan;89(1):36-44. (PMID: 8281670)
Eur J Heart Fail. 1999 Dec;1(4):337-52. (PMID: 10937947)
Am J Epidemiol. 2014 Jun 1;179(11):1331-9. (PMID: 24771724)
Curr Pharm Des. 2005;11(3):295-322. (PMID: 15723627)
Front Cell Dev Biol. 2019 Dec 03;7:314. (PMID: 31850348)
J Clin Invest. 2013 Aug;123(8):3201-3. (PMID: 23908120)
Mol Cells. 2011 Mar;31(3):225-30. (PMID: 21350939)
Blood Purif. 2014;38(1):1-6. (PMID: 25196674)
Endocrine. 2010 Apr;37(2):336-43. (PMID: 20960272)
FASEB J. 2006 Sep;20(11):1898-900. (PMID: 16891619)
Nephrol Dial Transplant. 2004 Jun;19(6):1412-9. (PMID: 15034162)
Nephron Clin Pract. 2003;95(3):c100-4. (PMID: 14646370)
Am J Nephrol. 2009;29(2):109-15. (PMID: 18701818)
Transpl Immunol. 2003 Apr-Jun;11(2):137-45. (PMID: 12799196)
Nephrol Dial Transplant. 2002 Jul;17(7):1189-96. (PMID: 12105240)
Lancet. 2012 Jan 14;379(9811):165-80. (PMID: 21840587)
Am J Pathol. 2011 Oct;179(4):1733-45. (PMID: 21871427)
Atherosclerosis. 2013 Apr;227(2):408-13. (PMID: 23375682)
Surgery. 2015 Jan;157(1):155-62. (PMID: 25444221)
Ren Fail. 2010;32(8):941-6. (PMID: 20722561)
Kidney Int. 2011 Jul;80(1):93-104. (PMID: 21289597)
J Am Soc Nephrol. 2015 Feb;26(2):439-47. (PMID: 25145930)
Kidney Blood Press Res. 2009;32(4):276-83. (PMID: 19797911)
J Am Soc Nephrol. 2001 Apr;12(4):736-748. (PMID: 11274235)
Kidney Int. 2010 Dec;78(12):1275-80. (PMID: 20844474)
Circ Res. 1996 Oct;79(4):812-20. (PMID: 8831505)
Cell Signal. 2020 Apr;68:109506. (PMID: 31862399)
Diabetes Res Clin Pract. 2010 Mar;87(3):335-41. (PMID: 20096949)
J Vasc Surg. 2003 Jul;38(1):162-9. (PMID: 12844106)
Circulation. 2009 Apr 28;119(16):2209-16. (PMID: 19364980)
ESC Heart Fail. 2017 Aug;4(3):321-330. (PMID: 28772055)
Hum Pathol. 1999 Jul;30(7):795-802. (PMID: 10414498)
Nutr Metab Cardiovasc Dis. 2015 Aug;25(8):756-62. (PMID: 26026213)
Mol Cell Biochem. 2008 Jul;314(1-2):151-9. (PMID: 18454303)
Kidney Int. 2013 Sep;84(3):622-3. (PMID: 23989362)
Kidney Int. 2004 Mar;65(3):904-17. (PMID: 14871410)
Ann Med. 2008;40(4):312-20. (PMID: 18428024)
Br J Clin Pharmacol. 2017 Jun;83(6):1197-1204. (PMID: 28002889)
N Engl J Med. 1992 Feb 6;326(6):381-6. (PMID: 1729621)
Int Wound J. 2016 Aug;13(4):493-9. (PMID: 26012891)
J Vasc Surg. 2015 Feb;61(2):428-35. (PMID: 25441671)
Kidney Int. 1993 Dec;44(6):1266-72. (PMID: 8301928)
J Gerontol A Biol Sci Med Sci. 2000 Aug;55(8):B365-72. (PMID: 10952357)

Keywords: CKD; MMPs; PAD.; TIMPs; biomarkers; eGFR; metalloproteinases; peripheral vascular disease; proteinuria

EC 3.4.24.- (Matrix Metalloproteinases)

Date Created: 20200123 Date Completed: 20210315 Latest Revision: 20240328

20240329

PMC7022805

10.3390/biom10010154

31963569